Bioavailability of Dienogest 2.0 mg With Regards to Reference Product
Status:
Completed
Trial end date:
2019-12-24
Target enrollment:
Participant gender:
Summary
This Pivotal study will investigate the bioavailability in women of 1 tablet formulations
containing Dienogest 2.0 mg. The Pivotal study will be performed at a single site with 30
subjects. Participants will take 1 tablet of the test product and reference product in 2
periods and 2 sequences (either test after reference or reference after test). There will be
a washout of at least 14 days between each study period.